Presentation TCT 2024 TCT 228: Treatment Modifications in Ticagrelor-Treated Patients: Insights From the FORCE-ACS Registry Presenter: Niels van der Sangen October 27, 2024
Presentation TCT 2024 TCT 401: Impact of >12-Month Versus =12-Month Dual Antiplatelet Therapy on Long-Term Outcomes After Chronic Total Occlusion Percutaneous Coronary Intervention Presenter: Yao Jiang October 27, 2024
Presentation TCT 2024 TCT 286: Impact of Dual Antiplatelet Therapy on Secondary Revascularization due to Native Vessel Disease Progression v/s Graft Failure After Coronary Artery Bypass Graft Presenter: IFTIKHAR CH October 27, 2024
Presentation TCT 2024 Antiplatelet Therapy and All-Cause Mortality After Transcatheter Aortic Valve Replacement: The TRITAVI Registry Presenter: Francesco Pelliccia October 27, 2024
Presentation TCT 2024 TCT 230: Ticagrelor Monotherapy vs. Ticagrelor Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk: A Post-Hoc Analysis of the TWILIGHT Trial Presenter: Mauro Gitto October 27, 2024
Presentation TCT 2024 TCT 229: Rebound Phenomenon of Platelet Reactivity After Cessation of Long-term Clopidogrel Therapy Presenter: Jung-Kyu Han October 27, 2024
Presentation TCT 2024 TCT 231: Safety of Aspirin-Free Prasugrel Monotherapy After PCI: Pooled Analysis of Three Months Outcomes in 508 Patients From ASET-I and ASET-Japan Trials Presenter: KOTARO MIYASHITA October 27, 2024
Presentation TCT 2024 TCT 227: Timing and Indications for Cangrelor Use and Transition Modalities to Oral P2Y12 Inhibitors in Patients Undergoing PCI: Insights From the SMILE Study Presenter: Angelo Oliva October 27, 2024
Presentation TCT 2024 TCT 4: Rationale and Design of the IMODERN STOP-IMH Randomized Trial: The Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for STEMI and the Effect on Intramyocardial Haemorrhage Presenter: Bahram Yosofi October 27, 2024
Presentation TCT 2024 TCT 1: Differential Outcomes in ST-Elevation and Non-ST Elevation Myocardial Infarction Outcomes After Percutaneous Coronary Intervention With Versus Without Cangrelor Presenter: Andrew Hill October 27, 2024
Presentation TCT 2024 TCT 5: Safety and Efficacy of Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Myocardial Infarction: A Meta-Analysis of RCTs Presenter: Sheref Elseidy October 27, 2024
Presentation TCT 2024 TCT 3: Ticagrelor Monotherapy After Coronary Stenting in Patients With Acute Myocardial Infarction (TIMO-AMI Study) Presenter: Oskar Angerås October 27, 2024
Presentation TCT 2024 TCT 2: Less Bleeding by Omitting Aspirin in Non-ST-Segment Elevation Acute Coronary Syndrome Patients (LEGACY) Presenter: Shabiga Sivanesan October 27, 2024
Presentation TCT 2024 TCT 6: Aspirin-Free Prasugrel Monotherapy After PCI in Patients With Non-ST Elevation Acute Coronary Syndrome Presenter: KOTARO MIYASHITA October 27, 2024
Presentation TCT 2024 TCT 238: Safety and Efficacy of Cangrelor: A Multicenter Nationwide Registry ARECA (Austrian Registry for Cangrelor Application) Presenter: Guy Friedrich October 27, 2024
Presentation TCT 2024 TCT 234: Sex Differences in the Safety and Efficacy of Short-term DAPT Versus DAPT De-escalation After Percutaneous Coronary Intervention Presenter: Donna Lin October 27, 2024
Presentation TCT 2024 TCT 237: Long-Term Clopidogrel vs Aspirin Monotherapy in Stable Coronary Artery Disease Patients With High Ischemic Risk: A Post Hoc Analysis of the HOST-EXAM Extended Study Presenter: Jeehoon Kang October 27, 2024
Presentation TCT 2024 TCT 236: Bailout Use of Cangrelor During Percutaneous Coronary Intervention and Associated Inpatient Outcomes Presenter: Abhishek Chaturvedi October 27, 2024
News Daily News SCAI Releases Practical, Technical Advice for Primary PCI in STEMI Michael O'Riordan October 10, 2024
News Daily News New Guidelines for CV Care in Patients Undergoing Noncardiac Surgery Michael O'Riordan September 24, 2024